What are the most useful and trustworthy noninvasive anatomic markers of existing vascular disease?

Current Cardiology Reports

Volumn 8, Issue 6, 2006, Pages 439-445

  Chow, Benjamin J W ^b   Veinot, John P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DEVELOPED COUNTRY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; ELECTRON BEAM TOMOGRAPHY; EVIDENCE BASED MEDICINE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INTRAVASCULAR ULTRASOUND; MOLECULAR DYNAMICS; MORBIDITY; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; TEMPERATURE MEASUREMENT;

ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33751048207     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0102-2     Document Type: Review

References (52)

1. Muller JE, Tawakol A, Kathiresan S, Narula J: New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaques. J Am Coll Cardiol 2006, 47:C2-C6.
2. Ambrose JA, Winters SL, Arora RR, et al.: Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol 1986, 7:472-478.
3. Little WC, Constantinescu M, Applegate RJ, et al.: Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988, 78:1157-1166.
4. Lafont A: Basic aspects of plaque vulnerability. Heart 2003, 89:1262-1267.
5. Spagnoli LG, Bonanno E, Mauriello A, et al.: Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002, 40:1579-1588.
6. Naghavi M, Libby P, Falk E, et al.: From vulnerable plaque to vulnerable patient - a call for new definitions and risk assessment strategies: Part II. Circulation 2003, 108:1772-1778.
7. Weissberg PL: Atherogenesis: current understanding of the causes of atheroma. Heart 2000, 83:247-252.
8. Toutouzas K, Vaina S, Tsiamis E, et al.: Detection of increased temperature of the culprit lesion after recent myocardial infarction: the favorable effect of statins. Am Heart J 2004, 148:783-788.
9. Stary HC, Blankenhorn DH, Chandler AB, et al.: A definition of the intima of human arteries and of its atherosclerosis- prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1992, 85:391-405.
10. Falk E: Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006, 47:C7-C12.
11. Dickson BC, Gotlieb AI: Towards understanding acute destabilization of vulnerable atherosclerotic plaques. Cardiovasc Pathol 2003, 12:237-248.
12. Stary HC: Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol 2000, 20:1177-1178.
13. Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the Vulnerable Plaque. J Am Coll Cardiol 2006, 47:C13-C18.
14. Farb A, Tang AL, Burke AP, et al.: Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 1995, 92:1701-1709.
15. Virmani R, Kolodgie FD, Burke AP, et al.: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262-1275.
16. Veinot JP, Srivatsa S, Carlson P: Beta3 integrin--a promiscuous integrin involved in vascular pathology. Can J Cardiol 1999, 15:762-770.
17. Abedin M, Tintut Y, Demer LL: Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004, 24:1161-70.
18. Glagov S, Weisenberg E, Zarins CK, et al.: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316:1371-1375.
19. Fuster V, Stein B, Ambrose JA, et al.: Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation 1990, 82:II-47-II-59.
20. Richardson PD, Davies MJ, Born GVR: Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989, 2:941-944.
21. Kullo IJ, Edwards WD, Schwartz RS: Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med 1998, 129:1050-1060.
22. Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med 1999, 340:115-126.
23. Torzewski J: C-Reactive protein and atherogenesis: new insights from established animal models. Am J Pathol 2005, 167:923-925.
24. Sun H, Koike T, Ichikawa T, et al.: C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol 2005, 167-1139-1148.
25. Khreiss T, Jozsef L, Potempa LA, Filep JG: Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res 2005, 97:690-697.
26. Yeh ETH: A new perspective on the biology of C-reactive protein. Circ Res 2005, 97:609-611.
27. Burke AP, Farb A, Malcom GT, et al.: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336:1276-1282.
28. Burke AP, Farb A, Malcom GT, et al.: Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998, 97:2110-2116.
29. Nissen SE: Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Am J Med 2005, 118(Suppl 12A):22-27.
30. Nissen SE, Tuzcu EM, Schoenhagen P, et al.: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004, 291:1071-1080.
31. Burgstahler C, Reimann A, Beck T, et al.: Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography. Int J Cardiovasc Imaging 2006, 22:119-121.
32. Hartung D, Sarai M, Petrov A, et al.: Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 2005, 46:2051-2056.
33. Agatston AS, Janowitz WR, Hildner FJ, et al.: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
34. Burke AP, Weber DK, Kolodgie FD, et al.: Pathophysiology of calcium deposition in coronary arteries. Herz 2001, 26:239-244.
35. Greenland P, LaBree L, Azen SP, et al.: Coronary artery calcium score combined with framingham score for risk prediction in asymptomatic individuals. JAMA 2004, 291:210-215.
36. Pletcher MJ, Tice JA, Pignone M, Browner WS: Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004, 164:1285-1292.
37. Van Mieghem CA, McFadden EP, de Feyter PJ, et al.: Non-invasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS). J Am Coll Cardiol 2006, 47:1134-1142.
38. Shah PK: Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003, 41:15S-22S.
39. Leber AW, Becker A, Knez A, et al.: Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol 2006, 47:672-677.
40. Komatsu S, Hirayama A, Omori Y, et al.: Detection of coronary plaque by computed tomography with a novel plaque analysis system, 'plaque map', and comparison with intravascular ultrasound and angioscopy. Circ J 2005, 69:72-77.
41. Bengel FM: Atherosclerosis imaging on the molecular level. J Nucl Cardiol 2006, 13:111-118.
42. Carrio I, Pieri PL, Narula J, et al.: Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol 1998, 5:551-557.
43. Lees AM, Lees RS, Schoen FJ, et al.: Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis 1988, 8:461-470.
44. Johnson LL, Schofield L, Donahay T, et al.: 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 2005, 46:1186-1193.
45. Dey D, Slomka P, Chien D, et al.: Direct quantitative in vivo comparison of calcified atherosclerotic plaque on vascular MRI and CT by multimodality image registration. J Magn Reson Imaging 2006, 23:345-354.
46. Yuan C, Mitsumori LM, Beach KW, Maravilla KR: Carotid atherosclerotic plaque: noninvasive NM characterization and identification of vulnerable lesions. Radiology 2001, 221:285-299.
47. Kampschulte A, Ferguson MS, Kerwin WS, et al.: Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 2004, 110:3239-3244.
48. Toussaint JF, Southern JF, Fuster V, Kantor HL: T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:1533-1542.
49. Barkhausen J, Ebert W, Heyer C, et al.: Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging. Circulation 2003, 108:605-609.
50. Sirol M, Itskovich VV, Mani V, et al.: Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation 2004, 109:2890-2896.
51. Ruehm SG, Corot C, Vogt P, et al.: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall super-paramagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001, 103:415-422.
52. Kooi ME, Cappendijk VC, Cleutjens KB, et al.: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003, 107:2453-2458.